B cell development is a complex process occurring in the fetal liver and then bone marrow. It begins with the proliferative expansion of progenitor cells that undergo sequential rearrangements of the *Ig heavy chain* (*Igh*) and *Ig light chain* (*Igl*) genes ([@bib54]; [@bib44]; [@bib27]). *Igh* variable region exons are assembled from variable (V~H~), diversity (D~H~), and joining (J~H~) gene segments, a recombination process that must be tightly regulated to ensure lineage and stage specificity, as well as highly ordered; D~H~ to J~H~ joining occurs first in pre-pro--B cells, followed by V~H~ to D~H~J~H~ recombination in pro--B cells. Productive V~H~D~H~J~H~ rearrangement results in the expression of a μ heavy chain that assembles with the surrogate light chains (λ5 and VpreB) to form a pre--BCR, which defines the pre--B cell differentiation stage. After further clonal expansion, pre--B cells undergo rearrangement of V~L~ and J~L~ elements in the *Igl* loci, resulting in transition to the immature B cell stage, marked by the cell surface expression of an IgM BCR. Ultimately, cells expressing functional, nonself-reactive BCRs are positively selected into the peripheral pool of long-lived mature B cells. These early B cell developmental steps are harmoniously regulated by transcriptional networks that integrate environmental cues to evoke gene expression programs appropriate to a particular developmental stage.

Emerging evidence has demonstrated that these transcriptional regulatory mechanisms on their own are not sufficient for proper B cell development and that posttranscriptional mechanisms are also required ([@bib30]). In regard to a general posttranscriptional regulator, attention has been recently paid to the CCR4--NOT multiprotein complex, which serves as one of the major deadenylases in eukaryotes ([@bib9]; [@bib45]). Deadenylation is the initial and often rate-limiting step in mRNA decay, resulting in the repression of translation ([@bib12]). The CCR4--NOT complex consists of two major modules: the deadenylase module composed of two subunits with deadenylation enzymatic activity (CNOT6 or CNOT6L and CNOT7 or CNOT8) and the NOT module, which minimally consists of the CNOT1 scaffold protein, CNOT2, and CNOT3. Although the precise function of the NOT module remains largely elusive, a recent study indicates that it regulates the stability and activity of the deadenylase module and participates in recruitment of the CCR4--NOT complex to its specific target mRNAs ([@bib65]). To ensure the target specificity, two targeting mechanisms have been proposed: first, sequence-specific RNA-binding proteins (RBPs) bring the CCR4--NOT complex to sequence elements in the 3′ untranslated region (3′-UTR) of the target mRNA, and second, instead of RBPs, the microRNA (miRNA) machinery recruits the CCR4--NOT complex to its target mRNA ([@bib65]). In addition to its central role in specific mRNA degradation, the CCR4--NOT complex has also been implicated in transcription initiation and elongation and protein degradation ([@bib9]; [@bib45]).

The physiological significance of CCR4--NOT-mediated regulation in mammals has been addressed by using conventional knockout mice. CNOT7 deficiency leads to defects in spermatogenesis and anomalies in bone formation ([@bib50]; [@bib67]) and CNOT3 ablation halts embryogenesis, whereas its haploinsufficiency results in anomalies of heart function, bone formation, and energy metabolism ([@bib51]; [@bib47]; [@bib68]). Although informative, the cellular and molecular bases of these severe phenotypes remain ill defined.

Here, we explored the role of CNOT3 in B cell development and activation and how, if at all, it participates in these processes. We first show that CNOT3 deficiency results in a developmental block at the pro- to pre--B cell transition. This developmental defect is attributable primarily to impaired *Igh* gene rearrangement in pro--B cells and increased apoptosis in pro- and pre--B cells. Notably, our data suggest that CNOT3 contributes to these biological phenomena both transcriptionally, by regulating initiation of germline transcription of the *Igh* locus, and posttranscriptionally, by deadenylating mRNA encoding the tumor suppressor *p53*.

RESULTS
=======

CNOT3 is essential for early B cell development
-----------------------------------------------

Because the CNOT3 subunit has been thought to be a key component for exerting the biological functions of the CCR4--NOT complex ([@bib10]), we decided to first focus on clarifying the function of CNOT3. We confirmed that CNOT3 and other subunits of the CCR4--NOT complex are expressed in the bone marrow during early B cell development and that CNOT3 protein is up-regulated in pro-B and pre--B cells ([Fig. 1 A](#fig1){ref-type="fig"} and not depicted). To determine its possible function at these developmental stages, we conditionally deleted *Cnot3* in B lineage cells by crossing with the mb1-cre deleter strain (*Cnot3^fl/fl^Mb1^cre/+^*; indicated as bKO hereafter; [Fig. 1, B--D](#fig1){ref-type="fig"}; [@bib20]). In bKO mice, floxed exons of the *Cnot3* allele and CNOT3 protein were efficiently deleted at the pro--B cell stage ([Figs. 1 E](#fig1){ref-type="fig"} and [2 A](#fig2){ref-type="fig"}). In the absence of CNOT3, other subunits of the complex were still expressed, although at somewhat decreased levels ([Fig. 1 F](#fig1){ref-type="fig"}). In bKO mice, the number of pro--B cells was increased to some extent, whereas pre--B cells were greatly reduced compared with control mice (*Cnot3^+/+^Mb1^cre/+^*). Immature and recirculating B cells in the bone marrow and B cells in the spleen were barely detectable ([Fig. 2, B--E](#fig2){ref-type="fig"}). Thus, CNOT3 is essential for the development of B lymphocytes and plays its critical role during the differentiation of pro-B to pre--B cells. A single *Cnot3* allele was sufficient to support normal B cell development ([Fig. 2, F and G](#fig2){ref-type="fig"}).

![**Generation of the *Cnot3* conditional knockout mice.** (A) Total lysates from 1.5 × 10^5^ sorted pre-pro-B (Lin^−^B220^+^IgM^−^CD43^+^CD25^−^CD19^−^) and pro--B cells (Lin^−^B220^+^IgM^−^CD43^+^CD25^−^CD19^+^) and 3 × 10^5^ pre-B (Lin^−^B220^+^IgM^−^CD43^−^CD25^+^), immature B (Lin^−^B220^int^IgM^+^), and recirculating B (Lin^−^B220^hi^IgM^+^) cells were separated by SDS-PAGE and immunoblotted with anti-CNOT3 antibody. Almost equal protein loading was confirmed by GAPDH. (B) Structure of the targeted *Cnot3* allele. Open triangles indicate loxP sequences. Numbered boxes represent exons in the *Cnot3* gene. Negative (HSV-TK) and positive (PGK-neo) selection markers are indicated by open rectangles (TK, thymidine kinase; neo, neomycin). The loxP-flanked neo-cassette was removed by transient transfection of the pIC-Cre vector into ES clones of *Cnot3^neo/+^* mice and PCR screening. Arrowheads indicate the position of the primers used in C and D. (C and D) PCR genotyping of genomic DNA isolated from *Cnot3^+/+^*, *Cnot3^neo/+^*, *Cnot3^null/+^*, and *Cnot3^flox/+^* mice using primers a--c (C) and primers d--f (D). (E) RNA-seq--mapped reads at the *Cnot3* locus from control and bKO pro--B cells. (F) Expression of subunits of the CCR4--NOT complex in control and bKO pro--B cells. Total lysates from 1.5 × 10^5^ sorted pro--B cells of control and bKO mice were separated by SDS-PAGE and immunoblotted with antibodies against the CCR4--NOT subunits. GAPDH, loading control. (A and F) Data are representative of two independent experiments.](JEM_20150384_Fig1){#fig1}

![**CNOT3 is essential for early B cell development.** (A) CNOT3 protein expression in sorted pre-pro--B (Lin^−^B220^+^IgM^−^CD43^+^CD25^−^CD19^−^) and pro--B (Lin^−^B220^+^IgM^−^CD43^+^CD25^−^CD19^+^) cells in the bone marrow from control and bKO mice was analyzed by Western blotting. GAPDH, loading control. (B and C) Flow cytometry (B) and absolute number of B cell subsets (C) of the bone marrow cells from control (*n* = 8) and bKO (*n* = 8) mice; B220^+^IgM^−^CD43^+^CD25^−^CD19^+^c-kit^+^ pro--B (Pro), B220^+^IgM^−^CD43^−^CD25^+^ pre--B (Pre), B220^int^IgM^+^ immature B (Imm), and B220^hi^IgM^+^ recirculating B (Rec) cells. (D and E) Flow cytometry (D) and absolute number (E) of splenic B cells (B220^+^CD3^−^) and T cells (B220^−^CD3^+^) from control (*n* = 8) and bKO (*n* = 8) mice. (F and G) Flow cytometry (F) and absolute number of B cell subsets (G) of bone marrow from *Cnot3^+/+^Mb1^cre/+^* (*n* = 5) and *Cnot3^fl/+^Mb1^cre/+^* (*n* = 6) mice; B220^+^IgM^−^ pro--B and pre-B (Pro/Pre), B220^int^IgM^+^ immature B, and B220^hi^IgM^+^ recirculating B cells. Numbers in B, D, and F indicate the percentage of cells. (H) Flow cytometry of intracellular Ig μ chain (intra μ) expression in pro--B cells from control, bKO, and *Rag1^−/−^* mice. Percentages indicate the frequency of intra μ--positive cells (bracketed line). (I, top) Schematic drawing of the germline *Igh* locus with the relative location of the different V~H~ family members. (bottom) PCR analysis of D~H~-J~H~ and V~H~-D~H~J~H~ rearrangements with fivefold serial dilutions of genomic DNA from sorted pro--B cells of control, bKO, and *Rag1^−/−^* mice. Cμ, loading control. (J) RT-PCR analysis of the expression of the rearranged D~H~-Cμ and V~H~-Cμ transcripts with fivefold serial dilutions of cDNA prepared from sorted pro--B cells of control, bKO, and *Rag1^−/−^* mice. Hprt, loading control; RT(−), no reverse transcription. (K) Frequency of apoptotic pro- and pre--B cells from mice of the indicated genotypes (*n* = 3--5), as assessed by positive staining of active caspase-3. (L) Flow cytometry analysis of surface expression of IL-7Rα on pro--B cells from control and bKO mice. Gray histogram, isotype control signal in control mice. Numbers indicate the mean fluorescence intensity of each population. (M) Relative mRNA expression levels of *Mcl1* in bKO pro--B cells compared with control pro--B cells, as determined by real-time qPCR. Error bar represents SD. *n* = 3 biological replicates. (C, E, G, and K) Each symbol represents a single mouse, and bars indicate the mean. (A--M) Data are representative of three (A, B, D, F, H, I, and J) or two (L and M) independent experiments or are pooled from three (C and E) or two (G and K) experiments. \*\*, P \< 0.01; \*\*\*, P \< 0.001; Student's *t* test.](JEM_20150384_Fig2){#fig2}

Successful V~H~D~H~J~H~ recombination and the resultant production of the Ig μ chain are essential for the pro-B to pre--B transition ([@bib29]; [@bib26]). We found that intracellular Ig μ protein levels were greatly reduced in bKO pro--B cells ([Fig. 2 H](#fig2){ref-type="fig"}). To directly address whether the impaired μ chain expression resulted from inefficient V~H~D~H~J~H~ recombination, the status of the *Igh* locus was examined in bKO pro--B cells. PCR analyses of genomic DNA isolated from pro--B cells clearly demonstrated that although D~H~ to J~H~ and the D~H~-proximal V~H~7183 to D~H~J~H~ rearrangements occur normally in bKO mice, the more distal V~H~Gam3.8 to D~H~J~H~ and the most distal V~H~J558 to D~H~J~H~ rearrangements were greatly impaired ([Fig. 2 I](#fig2){ref-type="fig"}). Consistently, the corresponding transcript levels correlated with the genomic DNA recombination frequency ([Fig. 2 J](#fig2){ref-type="fig"}). Collectively, these findings suggest the selective involvement of CNOT3 in recombination of the IgH distal V~H~ gene segments. However, the observed defect in the distal-specific V~H~-D~H~J~H~ recombination could also be explained by a survival defect of CNOT3-deficient pro--B cells, as B cells using the distal V~H~J558 family members expand at later stages of B cell development compared with those using the proximal V~H~7183 family ([@bib41]). In fact, staining of active caspase-3 revealed an approximately two- and fivefold higher frequency of apoptotic pro- and pre--B cells, respectively, in bKO mice ([Fig. 2 K](#fig2){ref-type="fig"}). Because IL-7 signaling is essential for survival of pro--B cells ([@bib40]), we examined its status, demonstrating that IL-7Rα surface expression as well as a downstream event, the mRNA expression of *Mcl1*, is unaffected by the loss of CNOT3 ([Fig. 2, L and M](#fig2){ref-type="fig"}). Thus, apparently normal IL-7 signaling takes place in the absence of CNOT3.

CNOT3 regulates pro--B cell survival by destabilizing *p53* mRNA
----------------------------------------------------------------

To clarify the molecular basis of the survival defect in CNOT3-deficient pro--B cells, we performed comprehensive gene expression profiling of control and bKO pro--B cells. Deep sequencing of mRNA and subsequent statistical analysis led to the identification of 79 up-regulated and 107 down-regulated genes in mutant cells ([Fig. 3 A](#fig3){ref-type="fig"} and [Table S1](http://www.jem.org/cgi/content/full/jem.20150384/DC1){#supp1}). Bioinformatic clustering with DAVID resources and KEGG pathway analysis ([@bib22]) revealed a significant enrichment of genes involved in the p53 signaling pathway among the differentially expressed genes ([Fig. 3, B and C](#fig3){ref-type="fig"}). The mRNA levels of molecules known to be important for early B cell development were not significantly affected by the loss of CNOT3 ([Fig. 3 D](#fig3){ref-type="fig"}), except for *Cd79a* (∼2-fold decrease) and *Irf4* (∼2.5-fold increase). In addition to the p53 signaling pathway, among factors related to the cell survival, *Pim1* (∼2-fold increase), *Mef2a* (∼2-fold decrease), and *Tgfbr1* (∼2-fold decrease; [@bib15]; [@bib42]; [@bib4]) were differentially expressed (Table S1), which might play a role in the survival defect of bKO pro--B cells.

![**Transcriptome analysis of control and bKO pro--B cells.** (A) A scatter plot of gene expression differences between control and bKO pro--B cells. RNA-seq was performed for sorted pro--B cells (Lin^−^B220^+^IgM^−^CD43^+^CD25^−^CD19^+^) for each genotype. Differentially expressed genes (FDR \<0.05) are highlighted in red (up-regulated in bKO) or blue (down-regulated in bKO). As our pro--B cell preparation for the RNA-seq comprises both c-kit^+^ pro--B cells and c-kit^−^ large pre--B cells, which are missing in bKO mice, these genes may also include those that are differentially regulated as a result of the analysis of a cell mixture. *n* = 4 biological replicates. (B) KEGG pathway enrichment analysis performed on differentially expressed genes between control and bKO pro--B cells using DAVID resources version 6.7. The most enriched 10 pathways based on their p-values are shown. (C) FPKM values of selected genes in the p53 signaling pathway in control and bKO pro--B cells. (D) Relative expression levels of selected molecules involved in early B cell development. FPKM values in bKO pro--B cells were normalized to those in control pro--B cells. (C and D) Error bars represent 95% confidence intervals. \*, q \< 0.05; \*\*, q \< 0.01.](JEM_20150384_Fig3){#fig3}

In this study, we focused on the p53 pathway because it is known to be involved in survival of early B lymphocytes ([@bib38]). Real-time quantitative PCR (qPCR) analysis revealed the significant elevation of *p53* mature mRNA in bKO pro--B cells ([Fig. 4 A](#fig4){ref-type="fig"}). We next determined whether this increase was caused by transcriptional and/or posttranscriptional regulation. There was no significant difference of the level of the *p53* unspliced transcript (pre-mRNA) between mutant and control pro--B cells ([Fig. 4 A](#fig4){ref-type="fig"}), indicating that CNOT3 likely down-modulates the level of mature *p53* mRNA in a posttranscriptional manner. This conclusion was further substantiated by the measurement of *p53* mature mRNA half-life, which was significantly longer in the absence of CNOT3 ([Fig. 4 B](#fig4){ref-type="fig"}). We next examined whether *p53* mRNA is directly targeted for deadenylation by the CCR4--NOT complex. A FLAG-tagged 3′-UTR of *p53* mRNA, but not of control *Gapdh* mRNA, associated with the CCR4--NOT complex in pro--B cell line lysates in vitro ([Fig. 4 C](#fig4){ref-type="fig"}); conversely, anti-CNOT3 antibody coimmunoprecipitated *p53* mRNA in wild-type pro--B cells ([Fig. 4 D](#fig4){ref-type="fig"}). These results indicate that physical association of the CCR4--NOT complex with the 3′-UTR of *p53* mRNA occurs in pro--B cells, although our data do not distinguish whether this association is direct or indirect. The targeting of the CCR4--NOT complex to *p53* mRNA resulted in shortening of the poly(A) tail; in the absence of CNOT3, the poly(A) tail length of the *p53* transcripts was significantly elongated, as revealed by the ligase-mediated poly(A) test (LM-PAT) assay ([Fig. 4 E](#fig4){ref-type="fig"}; [@bib57]). A similar effect of the CNOT3 deficiency on *p53* mRNA was also seen in pre--B cells ([Fig. 5, A and B](#fig5){ref-type="fig"}).

![**CNOT3-mediated posttranscriptional regulation of *p53* mRNA.** (A) Relative expression levels of spliced *p53* mature mRNA and unspliced pre-mRNA in bKO pro--B cells compared with control pro--B cells, as determined by real-time qPCR. Error bars represent SD. *n* = 4 biological replicates. RT(−), no reverse transcription. (B) Stability of *p53* mature mRNA. Pro--B cells from control and bKO mice were treated with actinomycin D for the indicated periods of time, and the relative mRNA levels compared with time 0 were determined by real-time qPCR. Data are shown as mean ± SD of *n* = 3 biological replicates. (C) Association of CNOT1 and CNOT3 with the 3′-UTR of *p53* mRNA. FLAG-tagged 3′-UTRs of *p53* and *Gapdh* mRNA were incubated with lysates of an Abelson virus--transformed pro--B cell line and immunoprecipitated with anti-FLAG antibody, followed by Western blotting. (D) Association of CNOT3 with *p53* mRNA by RIP assay. Wild-type pro--B cell lysates were immunoprecipitated with anti-CNOT3 antibody or control IgG, and the immunoprecipitates were analyzed by RT-PCR with primers specific to *p53* and *Gapdh* mRNA. (E) Poly(A) tail length of *p53* mRNA in pre-pro--B and pro--B cells of control and bKO mice was determined by the LM-PAT assay. (F) Flow cytometry of intracellular p53 protein expression in pro--B cells from control, bKO, and *p53^−/−^* mice. Numbers indicate the mean fluorescence intensity of each population. Data are representative of three independent experiments. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001; Student's *t* test.](JEM_20150384_Fig4){#fig4}

![**Analysis of p53 pathway genes in pro-B and pre--B cells.** (A) Real-time qPCR analysis of the relative mRNA expression levels of *p53*, *Puma*, *Bax*, and *p21* in pre--B cells of bKO mice, normalized by control pre--B cells. (B) Poly(A) tail length of *p53* mRNA in pre--B cells of control and bKO mice was determined by the LM-PAT assay. (C) Real-time qPCR to analyze the relative mRNA expression levels of *Puma*, *Bax*, and *p21* in pro--B cells from the indicated mice compared with those in control pro--B cells. (D) Stability of *Puma*, *Bax*, and *p21* mRNAs was analyzed by real-time qPCR as described in [Fig. 4 B](#fig4){ref-type="fig"}. Data are shown as mean ± SD of *n* = 3 biological replicates. (E) Flow cytometry of intracellular p53 protein expression in pro--B cells from control, bKO, bKO × *p53^+/−^*, and *p53^−/−^* mice. Numbers indicate the mean fluorescence intensity of each population. (F) Real-time qPCR to analyze the relative mRNA expression levels of *p53*, *Puma*, *Bax*, and *p21* in pro--B cells from bKO × *p53^+/−^* mice compared with control pro--B cells. (A, C, and F) Error bars represent SD. *n* = 3 biological replicates. Data are representative of two independent experiments. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001; Student's *t* test.](JEM_20150384_Fig5){#fig5}

The increase in *p53* mRNA in bKO pro--B cells was about twofold ([Fig. 4 A](#fig4){ref-type="fig"}), whereas the increase in p53 protein was more dramatic ([Fig. 4 F](#fig4){ref-type="fig"}). This difference could be the result of enhanced translational efficiency caused by the elongated poly(A) tail and/or by release of poly(A) tail--independent translational repression imposed by the CCR4--NOT complex ([@bib11]).

We also confirmed the up-regulation of p53 target mRNAs encoding proapoptotic factors, *Puma* and *Bax*, and a cell cycle regulator, *p21*, in bKO pro--B and pre--B cells ([Fig. 5, A and C](#fig5){ref-type="fig"}). However, in contrast to the case of *p53* ([Fig. 4 B](#fig4){ref-type="fig"}), these mRNAs were not stabilized in mutant pro--B cells ([Fig. 5 D](#fig5){ref-type="fig"}); the *Puma* mRNA even appeared to be somewhat destabilized in the absence of CNOT3. Because the elevated *Puma*, *Bax*, and *p21* mRNA levels in mutant cells were normalized by additional deletion of the *p53* gene ([Fig. 5 C](#fig5){ref-type="fig"}), their up-regulation appears to be primarily caused by p53-mediated transcriptional regulation.

Genetic ablation of *p53* rescues the survival defect but not the impaired *Igh* gene rearrangement
---------------------------------------------------------------------------------------------------

Having demonstrated the activated p53 pathway in CNOT3-deficient pro--B cells, we wished to test whether this indeed results in a survival defect, causing the distal V~H~ to D~H~J~H~ recombination anomaly. The ideal way to do this would be to restore the p53 level to the near normal, but not null, level in the CNOT3-knockout background. For this purpose, we considered using bKO × *p53^+/−^* mice; however, their pro--B cells were found to express higher levels of p53 protein and its target mRNAs such as *Puma* compared with control pro--B cells ([Fig. 5, E and F](#fig5){ref-type="fig"}). Therefore, instead, bKO × *p53^−/−^* mice were used to address the putative cause--effect relationship. As shown in [Fig. 2 K](#fig2){ref-type="fig"}, the proportion of apoptotic cells in bKO pro--B/pre--B cells was restored to the level of control cells by genetic ablation of *p53*. Moreover, the reduced pre--B cell numbers in bKO mice were significantly restored, albeit incompletely, upon loss of *p53* ([Fig. 6, A and B](#fig6){ref-type="fig"}). Importantly, we found that the decreased percentage of intra μ--positive cells among bKO pro--B cells could not be complemented by p53 deletion ([Fig. 6 C](#fig6){ref-type="fig"}). Consistent with this result, rearrangement of distal V~H~J558 and V~H~Gam3.8 to D~H~J~H~ and the resultant V~H~Cμ transcripts could hardly be detected in pro--B cells deficient in both CNOT3 and p53 ([Fig. 6, D and E](#fig6){ref-type="fig"}). Based on these data, we conclude that CNOT3 is a novel regulator of IgH distal V~H~ to D~H~J~H~ recombination.

![**Analysis of *Cnot3* and *p53* double-deficient mice.** (A and B) Flow cytometry (A) and absolute number of B cell subsets (B) in the bone marrow cells from the indicated mice (*n* = 5--7) using the same gating strategy as in [Fig. 2 (B and C)](#fig2){ref-type="fig"}. (B) Each symbol represents a single mouse, and bars indicate the mean. \*, P \< 0.05; \*\*\*, P \< 0.001; Student's *t* test. (C) Flow cytometry of intra μ expression in pro--B cells from control × *p53^−/−^*, bKO × *p53^−/−^*, and *Rag1^−/−^* mice. Percentages indicate the frequency of intra μ--positive cells (bracketed line). (D) PCR analysis of V~H~-D~H~J~H~ rearrangements with fivefold serial dilutions of genomic DNA from sorted pro--B cells of control × *p53^−/−^* and bKO × *p53^−/−^* mice. (E) RT-PCR analysis of the expression of the rearranged V~H~-Cμ transcripts with fivefold serial dilutions of cDNA prepared from sorted pro--B cells of control × *p53^−/−^* and bKO × *p53^−/−^* mice. (A--E) Data are representative of three independent experiments (A and C--E) or are pooled from three experiments (B).](JEM_20150384_Fig6){#fig6}

CNOT3 is required for the efficient *Igh* distal V~H~ to D~H~J~H~ rearrangement
-------------------------------------------------------------------------------

Distal V~H~ to D~H~J~H~ rearrangement is known to be selectively affected by deficiencies in several molecules such as in the B cell commitment factor Pax5 ([@bib17]), the general transcription factor YY1 ([@bib36]), and the histone modifier Ezh2 ([@bib61]); however, all of these genes were expressed at comparable levels in bKO and control pro--B cells ([Fig. 3 D](#fig3){ref-type="fig"}). Given that proximal V~H~ to D~H~J~H~ rearrangement occurred normally in bKO pro--B cells, the diminished distal V~H~ to D~H~J~H~ recombination in CNOT3-deficient pro--B cells seemed likely caused by limited accessibility of these particular V~H~ loci to the recombination machinery.

According to a recently proposed model ([@bib64]), germline transcription across the *Igh* locus ([@bib69]) plays a key role in facilitating locus compaction, which juxtaposes the distant V~H~ genes and D~H~J~H~ segments, allowing access to these distal genes for efficient recombination ([@bib31]; [@bib58]; [@bib25]). We found that the germline transcripts (GLTs) that initiate from the heavy chain intronic enhancer (Iμ) and from the most 3′ D segment (DQ52) promoter (μ0) were comparably abundant in control and bKO pro--B cells on a *Rag1^−/−^* background ([Fig. 7 A](#fig7){ref-type="fig"}). The levels of intergenic antisense transcripts from Pax5-associated intergenic repeat (PAIR) elements, PAIR4 and PAIR6, which are the major intergenic antisense transcripts induced by Pax5 and are thought to be involved in the regulation of distal V~H~-D~H~J~H~ recombination ([@bib14]; [@bib64]), were also unaffected by the absence of CNOT3. In contrast, the GLTs in the proximal V~H~7183 gene segments were somewhat decreased in bKO × *Rag1^−/−^* pro--B cells. Strikingly, both sense and antisense GLTs in the distal V~H~J558 gene segments were greatly reduced in these cells ([Fig. 7 A](#fig7){ref-type="fig"}). To determine whether this decrease is caused by transcriptional or posttranscriptional events, expression levels of newly transcribed nascent RNA were quantified by pulse labeling of pro--B cells with a uridine analogue, 5-ethynyl uridine (EU), which is efficiently incorporated into the nascent RNA. Quantification of the EU-incorporated RNAs revealed that nascent V~H~7183 GLTs were reduced ∼60% and nascent V~H~J558 GLTs were reduced more than ∼95% in bKO × *Rag1^−/−^* pro--B cells ([Fig. 7 B](#fig7){ref-type="fig"}). Thus, CNOT3 is highly suggested to be required for the germline transcription of the *Igh* V genes, particularly in the distal V~H~J558 family. In contrast, nascent *p53* mRNA levels were comparable between control and CNOT3-deficient cells, consistent with the unaltered *p53* pre-mRNA levels in bKO pro--B cells described above ([Fig. 4 A](#fig4){ref-type="fig"}).

![**Involvement of CNOT3 in the V~H~ germline transcription and the *Igh* locus contraction.** (A) RT-PCR analysis of the *Igh* GLTs, strand-specific V~H~J558 GLTs, V~H~7183 GLTs (including sense and antisense strands), PAIR4, PAIR6, Iμ, and μ0, with fivefold serial dilutions of cDNA prepared from sorted pro--B cells (B220^+^CD19^+^c-kit^+^) of control × *Rag1^−/−^* and bKO × *Rag1^−/−^* mice. u and s, unspliced and spliced transcripts, respectively. Hprt, loading control; RT(−), no reverse transcription. (B) Quantification of newly transcribed nascent RNA levels of V~H~J558 GLTs (including sense and antisense strands), V~H~7183 GLTs, *p53* mRNA, and *Hprt* mRNA. Pro--B cells were pulse-labeled with vehicle (−EU) or EU (+EU) for 30 min, and the EU-labeled nascent RNAs were quantified by real-time qPCR and normalized to the control × *Rag1^−/−^* (+EU) sample. Error bars represent SD. *n* = 3 biological replicates. \*\*, P \< 0.01; \*\*\*, P \< 0.001; Student's *t* test. (C--E) 3D DNA-FISH analysis of the *Igh* locus of control × *Rag1^−/−^* pro--B, bKO × *Rag1^−/−^* pro--B, and wild-type splenic CD4 T cells. (C) Confocal images of *Igh* segments and nuclear envelope (anti--Lamin B1, blue). Bars, 2 µm. (D and E) Quantification of the intralocus distances between V~H~J558 (D) or V~H~7183 (E) and C~H~ signals. Red lines indicate the mean distance of at least 100 alleles per each cell type. \*\*\*, P \< 0.001; unpaired Student's *t* test. Loss of CNOT3 did not largely affect the nuclear periphery-to-center repositioning of the *Igh* locus. Percentages of V~H~J558 probes at the nuclear periphery, defined as a distance of \<0.5 µm between V~H~ probes and nuclear envelope (Lamin B1), are 11.6% (control × *Rag1^−/−^* pro--B), 13.0% (bKO × *Rag1^−/−^* pro--B), and 25.5% (wild-type splenic CD4 T). (A--E) Data are representative of three (A) or two (B--E) independent experiments.](JEM_20150384_Fig7){#fig7}

Next, we measured the distances between V~H~ probes (V~H~J558 or V~H~7183) and the constant region probe (C~H~) on the same *Igh* allele using three-dimensional DNA fluorescence in situ hybridization (3D DNA-FISH). The distribution of intralocus distances between V~H~J558 and C~H~ probes in control × *Rag1^−/−^* pro--B cells are more constrained compared with those in splenic CD4 T cells ([Fig. 7, C and D](#fig7){ref-type="fig"}), as reported previously ([@bib58]). We found that the absence of CNOT3 resulted in a significant increase in the spatial distances between the V~H~J558 and C~H~ loci compared with control pro--B cells, although the increase was not as extensive as seen in T cells ([Fig. 7, C and D](#fig7){ref-type="fig"}). In regard to the less extensive spatial distances compared with T cells, our data could not completely exclude the following possibility. Only a small amount of CNOT3 might be remaining, probably because of the late onset of *Cnot3* deletion by mb1-cre, thereby causing the less efficient decontraction of the *Igh* locus in bKO × *Rag1^−/−^* pro--B cells compared with T cells. In this regard, our deletion detection system might not have sufficed to detect such small changes. We also analyzed the distances between proximal V~H~7183 and C~H~ probes, showing they were not significantly affected in the absence of CNOT3 ([Fig. 7, C and E](#fig7){ref-type="fig"}). These results suggest that CNOT3 is required for the regulation of efficient compaction of the *Igh* locus in pro--B cells.

To test whether the inability of CNOT3-deficient pro--B cells to perform distal V~H~-D~H~J~H~ rearrangements contributes to the developmental block observed in vivo, we made use of the B1-8^hi^ mouse line, which carries a pre-rearranged V~H~D~H~J~H~ segment in the endogenous *Igh* locus ([@bib60]). As shown in [Fig. 8 (A and B)](#fig8){ref-type="fig"}, compared with bKO mice, bKO × B1-8^hi^ mice displayed increased numbers of pre--B and immature B cells in the bone marrow, indicating that the developmental block imposed by CNOT3 ablation was partially alleviated by the introduction of the pre-rearranged V~H~D~H~J~H~ segment. Note that *Cnot3^fl^* alleles were efficiently deleted in bKO and bKO × B1-8^hi^ pre--B cells ([Fig. 8, C and D](#fig8){ref-type="fig"}). To address whether the only partial restoration of the pre--B cell population in bKO × B1-8^hi^ mice is caused by the inefficient *Igl* VJ rearrangements, we analyzed the V~κ~ to J~κ~ rearrangements at the *Igκ* locus in CNOT3-deficient pre--B cells. Genomic PCR and RT-PCR analyses revealed the V~κ~J~κ~ rearrangements and κ~o~ germline transcription were unaffected by the absence of CNOT3 ([Fig. 8, E and F](#fig8){ref-type="fig"}). Hence, rather, the still-augmented p53 pathway in bKO × B1-8^hi^ mice ([Fig. 8 C](#fig8){ref-type="fig"}) is likely to be one of the reasons for the partial restoration of the pre--B cell population in bKO × B1-8^hi^ mice.

![**Partial rescue of the differentiation defect in bKO mice by the introduction of pre-rearranged V~H~D~H~J~H~ segment.** (A and B) Flow cytometry (A) and absolute number of B cell subsets (B) of the bone marrow cells from the indicated mice (*n* = 3--6) using the same gating strategy as in [Fig. 2 (B and C)](#fig2){ref-type="fig"}. (B) Each symbol represents a single mouse, and bars indicate the mean. (C) Real-time qPCR to analyze the relative mRNA expression levels of *Cnot3*, *p53*, *Puma*, *Bax*, and *p21* in bKO × B1-8^hi^ pre--B cells, normalized by control × B1-8^hi^ pre--B cells. *Cnot3* primers are designed in the floxed exons to confirm efficient deletion of *Cnot3*. Error bars represent SD. *n* = 3 biological replicates. (D) PCR genotyping of pre--B cells of the indicated mice. The PCR fragments corresponding to wild-type, floxed, or deleted (Δ) alleles are indicated to the right. (E) PCR analysis of V~κ~-J~κ~1 rearrangements with fivefold serial dilutions of genomic DNA from sorted control × B1-8^hi^ pre--B cells, bKO × B1-8^hi^ pre--B cells, and *Rag1^−/−^* pro--B cells. Cμ, loading control. (F) RT-PCR analysis of the expression of the rearranged V~κ~-C~κ~ transcripts and κ~o~ GLTs with fivefold serial dilutions of cDNA prepared from sorted pre--B cells of control × B1-8^hi^ and bKO × B1-8^hi^ mice. Hprt, loading control; RT(−), no reverse transcription. (A--F) Data are representative of three (A) or two (C--F) independent experiments or are pooled from two experiments (B). \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001; Student's *t* test.](JEM_20150384_Fig8){#fig8}

DISCUSSION
==========

In the present work, we addressed the physiological function of CNOT3 and its action mechanisms by B cell--specific deletion of the *Cnot3* gene and by identifying functionally critical CNOT3 targets in the in vivo context. One of the causes of impaired B cell development in the absence of CNOT3 lies in reduced rearrangement of distal V~H~ genes, including the V~H~J558 family, as a result of defective V~H~ locus contraction. The fact that the V~H~J558 family is the largest V~H~ gene family that occupies the 5′ distal half of the V~H~ region explains the major reduction of intracellular μ chain--positive pro--B cells in the absence of CNOT3.

The mechanism by which each of the ∼200 V~H~ gene segments scattered over a 2.5-Mbp region has an equal opportunity to establish contact and recombine with the D~H~J~H~ element was a mystery until it was realized that large-scale locus contraction could occur through chromatin looping ([@bib31]; [@bib17]; [@bib58]; [@bib25]). Recent chromosome conformation capture sequencing experiments (4C-seq) have revealed the existence of two layers of chromatin contraction, local and large scale ([@bib43]). The local chromatin loops, ranging in length from 0.5 to 1.3 Mb, as well as V~H~ GLTs are observed even in the absence of Pax5 ([@bib19]). Subsequently, Pax5 and YY1 activate PAIRs, particularly PAIR4 and PAIR6, by inducing noncoding intergenic antisense transcripts, thereby promoting PAIRs to form the base of large-scale chromatin loops. Our data suggest that, similar to noncoding intergenic antisense transcripts, the V~H~J558 sense and antisense GLTs are likely to be required for the local chromatin looping, which, in turn, could be a prerequisite for subsequent large-scale looping mediated by Pax5 and YY1.

The mechanism by which CNOT3 induces V~H~J558 germline transcription remains elusive. The presence of defective nascent transcripts in the mutant pro--B cells makes the involvement of CNOT3 in the transcription processes by itself likely, although its participation in destabilization of mRNAs encoding suppressor-type transcription factors could not be completely excluded. In support of the transcriptional regulation model, recent genome-wide RNAi screening experiments identified CNOT3 as one of the molecules that form a unique module in the transcription network required for mouse embryonic stem (ES) cell self-renewal ([@bib21]). Assuming that CNOT3 participates in transcription processes, three possibilities could be envisaged: (1) regulating transcription initiation by its interaction with transcription factors ([@bib2]; [@bib34]; [@bib13]), (2) controlling transcription elongation by its binding to Pol II elongation factor Paf1c ([@bib32]), and (3) controlling histone modifications ([@bib33]; [@bib48]; [@bib51]).

The CCR4--NOT complex acts as one component for the nonsense-mediated mRNA decay (NMD) mechanism; aberrant mRNAs containing premature translation termination codons are detected by the NMD mechanism, thereby being degraded by the action of the CCR4--NOT complex ([@bib37]). For instance, in early B lymphocytes, nonsense *Igh* mRNA from a nonproductively rearranged allele is rapidly degraded by this mechanism ([@bib35]). Given the recent evidence for the importance of the NMD mechanism in development of early lymphocytes ([@bib16]; [@bib39]), it is possible that the NMD pathway is perturbed in the CNOT3-deficient pro--B cells, which may, at least to some extent, contribute to the defective pro-- to pre--B cell transition.

p53 contributes to the suppression of pro--B cell expansion during the checkpoint associated with *Igh* locus recombination and the subsequent formation of the pre--BCR ([@bib38]). This process requires the creation of DNA double-strand breaks and is thought to activate the p53 response, which initiates transcription of genes that arrest cell cycle and induce apoptosis ([@bib28]). Therefore, a reasonable speculation is that CNOT3-mediated suppression of p53 expression may allow pro--B cells to survive the physiological genomic stress required for proper recombination at the *Igh* locus and to subsequently facilitate the expansion of successfully recombined cells. Up-regulation of some subunits of the CCR4--NOT complex, including CNOT3, in pro-- and pre--B cell stages may support this speculation.

Because miRNAs are involved in the recruitment of the CCR4--NOT complex to the target mRNAs ([@bib65]), we anticipated that the phenotypes of CNOT3- and Dicer-deficient mice might have some overlap. However, key biological targets differ in these two mutant mice. Bim expression was dramatically increased in Dicer-deficient pro--B cells ([@bib30]) but was normal in the absence of CNOT3 ([Fig. 3 D](#fig3){ref-type="fig"} and not depicted). Given that CNOT1 interacts with the miRNA machinery--associated proteins GW182/TNRC6 ([@bib6]), one straightforward explanation among many is that even in the absence of the CNOT3 subunit, the CCR4--NOT complex, including the CNOT1 subunit, is recruited to the miRNA machinery, thereby functioning as a posttranscriptional regulator. In contrast, our data clearly demonstrate that CNOT3 is required for targeting the CCR4--NOT complex to *p53* mRNA. Considering the previous evidence that NOT3, a *Drosophila melanogaster* homologue of CNOT3, directly interacts with Bic-C, an RBP, thereby recruiting the CCR4--NOT complex to target mRNAs ([@bib8]), we would propose that the interaction between RBPs and CNOT3 for recruitment of the CCR4--NOT complex to *p53* mRNA is a possible mechanism operating in pro- and pre--B cells.

Such CNOT3-associated RBPs are thought to function by destabilizing on *p53* mRNA. Counteracting this action are stabilizing RBPs, for example HuR, which was initially identified as an AU-rich element-binding protein with a potential to stabilize mRNA ([@bib3]). By using Lck-Cre--dependent deletion of HuR, one study demonstrated that the transition through the β-selection checkpoint during T cell development (the TCRβ locus recombination stage) was promoted and that protein expression of p53 was reduced in HuR-deficient thymocytes ([@bib52]), suggesting that HuR functions as a positive regulator of *p53* mRNA stability in pro-- and pre--T cell stages. Hence, it is reasonable to anticipate that p53 expression is regulated posttranscriptionally, mediated by the balance of opposing RBPs, thereby contributing significantly to early lymphocyte development.

MATERIALS AND METHODS
=====================

### Mice.

To generate *Cnot3^fl/+^* mice, ES clones of *Cnot3^neo/+^* mice ([@bib47]) were transiently transfected with a pIC-Cre vector and screened by PCR and Southern blot analyses to select the clones in which the loxP flanked neo-cassette was correctly removed ([Fig. 1, B--D](#fig1){ref-type="fig"}). Positive ES clones were used for microinjection to obtain chimeric mice. These chimeric mice were then crossed with C57BL/6 mice to obtain animals with germline transmission of the targeted allele. *Cnot3^fl/+^* F1 mice were backcrossed to the C57BL/6 background for at least 10 generations. Homozygous mutant (*Cnot3^fl/fl^*) mice produced by crossing *Cnot3^fl/+^* heterozygotes were born at Mendelian ratios, were fertile, and had no obvious aberrant phenotype. Mb1-cre mice (provided by E. Hobeika and M. Reth, Max Planck Institute of Immunology and Epigenetics; [@bib20]), *p53^−/−^* mice ([@bib18]), B1-8^hi^ IgH knock-in mice (provided by M.C. Nussenzweig, The Rockefeller University, New York, NY; [@bib60]), and *Rag1^−/−^* mice (Jax 002216; JAX Mice database) are described elsewhere and were maintained on a C57BL/6 background. C57BL/6 mice were purchased from CLEA Japan. All mice were bred and maintained under specific pathogen--free conditions, and all animal experiments were performed under institutional guidelines of the RIKEN Yokohama Research Institute and Osaka University.

### Flow cytometry analysis.

7--12-wk-old experimental and control mice were used for cell type analyses. Single-cell suspensions of splenocytes and bone marrow cells from two tibiae and femurs lysed of red blood cells were stained with the fluorochrome-conjugated antibodies and analyzed using FACSCanto II (BD), and data were evaluated with FlowJo software. Anti-CD11b (M1/70), CD25 (PC61.5), CD43 (R2/60), CD117 (2B8), CD127 (A7R34), B220 (RA-6B2), IgM (II/41), F4/80 (BM8), Gr-1 (RB6-8C5), and TER-119 (TER-119) antibodies were from eBioscience. Anti-CD19 (1D3) antibody was from BD. Alexa Fluor 647--anti-p53 (1C12) antibody was from Cell Signaling Technology. Intracellular Ig μ staining was performed as described previously ([@bib55]). In brief, cells were first stained for surface antigens and then fixed, permeabilized, and stained with anti-IgM using an Intracellular Fixation & Permeabilization Buffer Set (eBioscience). Intracellular p53 staining was performed by using a Foxp3 staining kit (eBioscience) according to the manufacturer's instructions. For purification of the bone marrow cell populations, cells were first stained with a mixture of biotin-conjugated antibodies (anti-CD11b, F4/80, Gr-1, TER-119, and CD3ε), incubated with Streptavidin Microbeads (Miltenyi Biotec), and then enriched by depletion of labeled cells using autoMACS system (Miltenyi Biotec) before surface labeling for cell sorting (FACSAria II; BD). For active caspase-3 staining, equal numbers of the bone marrow cells were incubated in culture medium (IMDM supplemented with 10% FBS, nonessential amino acids, sodium pyruvate, 2-mercaptethanol, [l]{.smallcaps}-glutamine, and antibiotics) for 3 h at 37°C. After labeling with the appropriate antibodies, cells were stained with FITC-DEVD-FMK to detect active caspase-3 (CaspGLOW Fluorescein Active Caspase-3 Staining kit; eBioscience) according to the manufacturer's instructions.

### RNA analysis.

Total RNA was extracted from purified cell populations using TRIzol reagent (Invitrogen). For RT-PCR, DNase I (Invitrogen)--treated RNA was reverse transcribed with a mixture of random primers and oligo(dT) using a High Capacity RNA-to-cDNA kit (Applied Biosystems). Semi--qRT-PCR was performed using the primers listed below, and the PCR products were separated on agarose gels and visualized by ethidium bromide staining. Most primer sequences were described previously ([@bib59]; [@bib66]; [@bib17]; [@bib53]; [@bib36]; [@bib56]; [@bib14]). To measure strand-specific V~H~J558 GLTs, 50 ng of total RNA was reverse transcribed using strand-specific RT primers and Superscript II reverse transcription (Invitrogen), followed by semi--qRT-PCR as described previously ([@bib5]). Real-time qPCR was performed using Power SYBR Green PCR Master Mix and StepOnePlus Real-Time PCR systems (Applied Biosystems). All qPCR experiments were run with three technical replicates in 96-well plates. *Gapdh* mRNA levels were used for normalization. Primers used for qPCR analysis are listed below. For the analysis of mRNA stability, sorted pro--B cells were cultured in the presence of 5 µg/ml actinomycin D. Total RNA extracted at the indicated time points was subjected to real-time qPCR analysis. RNA-immunoprecipitation (RIP) assay was performed using the RiboCluster Profiler RIP-assay kit (MBL) according to the manufacturer's instructions using anti-CNOT3 monoclonal antibody, which has been generated by using bacterially expressed full-length CNOT3 as an immunogen (Bio Matrix Research Inc.) and control mouse IgG. Eluted RNA was analyzed by RT-PCR. To quantify newly transcribed nascent RNA levels, MACS-purified CD19^+^ pro--B cells (95--98% purity) were incubated with 0.5 mM EU (Invitrogen) for 30 min at 37°C. EU-labeled RNA was biotinylated and purified on Dynabeads MyOne Streptavidin T1 using Click-iT Nascent RNA Capture kit (Invitrogen) according to the manufacturer's instructions. The captured RNA on beads was reverse transcribed into cDNA, which was used as the template for real-time qRT-PCR analysis.

The following primers were used for RT-PCR analysis: V~H~J558-Cμ forward, 5′-CGAGCTCTCCARCACAGCCTWCATGCARCTCARC-3′; V~H~J558-Cμ reverse, 5′-ATGCAGATCTCTGTTTTTGCCTCC-3′; V~H~Gam3.8-Cμ forward, 5′-CAAGGGACGGTTTGCCTTCTCTTTGGAA-3′; V~H~Gam3.8-Cμ reverse, 5′-ATGCAGATCTCTGTTTTTGCCTCC-3′; V~H~7183-Cμ forward, 5′-CGGTACCAAGAASAMCCTGTWCCTGCAAATGASC-3′; V~H~7183-Cμ reverse, 5′-ATGCAGATCTCTGTTTTTGCCTCC-3′; D~H~-Cμ forward, 5′-TTCAAAGCACAATGCCTGGCT-3′; D~H~-Cμ reverse, 5′-ATGCAGATCTCTGTTTTTGCCTCC-3′; Hprt forward, 5′-GGGGGCTATAAGTTCTTTGCTGACC-3′; Hprt reverse, 5′-TCCAACACTTCGAGAGGTCCTTTTCAC-3′; V~H~J558 sense GLT RT primer, 5′-GAGCTTGCTGCACCTCCA-3′; V~H~J558 sense GLT forward, 5′-ATGGGATGGAGCTGGATCTT-3′; V~H~J558 sense GLT reverse, 5′-GACACACTCAGGATGTGTTTGTAG-3′; V~H~J558 antisense GLT RT primer, 5′-CACTGAACACACTGACTCTAACCA-3′; V~H~J558 antisense GLT forward, 5′-ATGGGATGGAGCTGGATCTT-3′; V~H~J558 antisense GLT reverse, 5′-GACACACTCAGGATGTGTTTGTAG-3′; V~H~7183 GLT forward, 5′-CGGTACCAAGAASAMCCTGTWCCTGCAAATGASC-3′; V~H~7183 GLT reverse, 5′-GTCTCTCCGCGCCCCCTGCTGGTCC-3′; PAIR4 forward, 5′-TCCATGTTAGTGGTGGCAGA-3′; PAIR4 reverse, 5′-GTGACGACGGCTCATGACTA-3′; PAIR6 forward, 5′-TCCATGTTAGTGGTGGCAGA-3′; PAIR6 reverse, 5′-TCTGCAGTGTGTGACGACAG-3′; Iμ forward, 5′-TTCCAATACCCGAAGCATTTAC-3′; Iμ reverse, 5′-GTCCATGAGCAGCCAGGTG-3′; μ0 forward, 5′-AACATCTGAGTTTCTGAGGCTTGG-3′; μ0 reverse, 5′-TCATCTGAACCTTCAAGGATGCTC-3′; p53 forward, 5′-CCTCCCGGTCCCTTCTGCTGCC-3′; p53 reverse, 5′-ATGCAGACAGGCTTTGCAGAATG-3′; Jκ-Cκ forward, 5′-GGCTGCAGSTTCAGTGGCAGTGGRTCWGGRAC-3′; Jκ-Cκ reverse, 5′-CTCATTCCTGTTGAAGCTCTTGACAATGGG-3′; κ~o~ forward, 5′-CAGTGAGGAGGGTTTTTGTACAGCCAGACAG-3′; and κ~o~ reverse, 5′-TTTCCAGCTTGGTCCCCCCTCCGAA-3′.

The following primers were used for real-time qPCR analysis: p53 mature mRNA forward, 5′-TATCAGCCTCGAGCTCCCTCTG-3′; p53 mature mRNA reverse, 5′-CAGCAACAGATCGTCCATGCAG-3′; p53 pre-mRNA forward, 5′-CATGCCCAACGCTCTTTGGTTC-3′; p53 pre-mRNA reverse, 5′-CTGCAGCCAAAGGTCCAGTTAC-3′; Puma forward, 5′-ATGGCGGACGACCTCAAC-3′; Puma reverse, 5′-AGTCCCATGAAGAGATTGTACATGAC-3′; Bax forward, 5′-GGAGCAGCTTGGGAGCG-3′; Bax reverse, 5′-AAAAGGCCCCTGTCTTCATGA-3′; p21 forward, 5′-CCGTTGTCTCTTCGGTCCC-3′; p21 reverse, 5′-CATGAGCGCATCGCAATC-3′; Cnot3 forward, 5′-CGCAAGAAGAAAGGCGACAAGG-3′; Cnot3 reverse, 5′-CGAGGTCCAGGTCGTCATAGAGG-3′; Gapdh forward, 5′-ATGGTGAAGGTCGGTGTGAACGGATTTGGC-3′; Gapdh reverse, 5′-AGCTTCCCATTCTCGGCCTGGACTGTTCTG-3′; Hprt forward, 5′-TCCTCCTCAGACCGCTTTT-3′; Hprt reverse, 5′-CCTGGTTCATCATCGCTAATC-3′; V~H~J558 GLT forward, 5′-ATGGGATGGAGCTGGATCTT-3′; V~H~J558 GLT reverse, 5′-GACACACTCAGGATGTGTTTGTAG-3′; V~H~7183 GLT forward, 5′-CGGTACCAAGAASAMCCTGTWCCTGCAAATGASC-3′; V~H~7183 GLT reverse, 5′-GTCTCTCCGCGCCCCCTGCTGGTCC-3′; Mcl1 forward, 5′-TCAAAGATGGCGTAACAAACTGG-3′; and Mcl1 reverse, 5′-CCCGTTTCGTCCTTACAAGAAC-3′.

### FLAG-tagged RNA-based immunoprecipitation assay.

Preparation of FLAG peptide--tagged RNAs was performed as described previously ([@bib1]). The PD31 Abelson virus--transformed pro--B cell line (provided by M. Schlissel, University of Michigan, Ann Arbor, MI) was expanded as described previously ([@bib49]) and lysed with a buffer containing 20 mM Hepes-NaOH, pH 7.5, 150 mM NaCl, 50 mM NaF, 1 mM Na~3~VO~4~, 1% digitonin, protease inhibitor cocktail (Roche), and phosphatase inhibitor cocktail (Nacalai Tesque). FLAG-tagged RNA (10 pmol) was mixed with anti--FLAG M2 agarose (Sigma-Aldrich) and subjected to immunoprecipitation with the cell lysate. The immunoprecipitates eluted with 3× FLAG peptide (Sigma-Aldrich) were analyzed by Western blotting.

### RNA-seq and pathway analysis.

Total RNA was extracted from sorted cells by using TRIzol reagent. The DNA library for RNA-seq analysis was constructed with a TruSeq RNA sample prep kit (Illumina) as instructed by the supplier. The size range of the resulting DNA library was estimated on a 2100 Bioanalyzer (Agilent Technologies). After checking the molar concentration by qPCR using a LightCycler 480 (Roche), the DNA library was subjected to sequencing on a HiSeq 1000 sequencer (Illumina) in a 100-bp single-end read mode. The raw data were processed with CASAVA 1.8.2 (Illumina) to generate fastq files. The sequence reads were aligned to the *Mus musculus* reference genome (Build 37) using TopHat version 2.0.13 ([@bib62]). According to the mapped data, Cufflinks version 2.2.1 ([@bib63]) was used to calculate the fragments per kilobase of exon per million reads (FPKM) with the *M. musculus* genome annotation NCBI build 37.2 downloaded from its website. The statistical significance of the differential gene expression between cell populations was evaluated using the Cuffdiff software version 2.2.1 ([@bib63]). Genes with false discovery rate (FDR) \<0.05 were selected as differentially expressed ones. Four biological replicates were used in each genotype. For pathway analysis of the differentially expressed genes, we used DAVID resources version 6.7. The RNA-seq data are available at Gene Expression Omnibus database under accession no. [GSE64455](GSE64455).

### V(D)J recombination analysis.

Genomic DNA was isolated from sorted pro--B or pre--B cells by phenol extraction and ethanol precipitation. PCR analyses were performed using published primers as described previously ([@bib59]; [@bib17]), and PCR conditions were adjusted to be in the linear amplification range by serial dilution of template DNA. Samples from *Rag1^−/−^* pro--B cells serve as a negative control for D~H~ to J~H~, V~H~ to D~H~J~H~, and V~κ~ to J~κ~ recombination experiments. The PCR products were separated on agarose gels and visualized by ethidium bromide staining.

The following primers were used for V(D)J recombination analysis: V~H~J558 forward, 5′-CGAGCTCTCCARCACAGCCTWCATGCARCTCARC-3′; V~H~Gam3.8 forward, 5′-CAAGGGACGGTTTGCCTTCTCTTTGGAA-3′; V~H~7183 forward, 5′-CGGTACCAAGAASAMCCTGTWCCTGCAAATGASC-3′; D~H~ forward, 5′-TTCAAAGCACAATGCCTGGCT-3′; J~H~3 reverse, 5′-GTCTAGATTCTCACAAGAGTCCGATAGACCCTGG-3′; V~κ~ forward, 5′-GGCTGCAGSTTCAGTGGCAGTGGRTCWGGRAC-3′; J~κ~1 reverse, 5′-GCCACAGACATAGACAACGGAAGAA-3′; Cμ forward, 5′-TGGCCATGGGCTGCCTAGCCCGGGACTT-3′; and Cμ reverse, 5′-GCCTGACTGAGCTCACACAAGGAGGA-3′.

### LM-PAT assay.

LM-PAT assay was performed as described previously ([@bib57]) with some modifications. In brief, the poly(A) tails of total RNAs (500 ng) were first saturated with 5′-phosphorylated oligo(dT)~12--18~ at 42°C in the presence of T4 DNA ligase. Then, the excess amount of oligo(dT) anchor primer (5′-GCGAGCTCCGCGGCCGCGTTTTTTTTTTTT-3′) was added to the reaction to anneal at the end of poly(A) tails and incubated for 2 h at 12°C to complete ligation. This ligated primer was subjected to prime RT using SuperScript II (Invitrogen). PCR was performed with an anchor primer (5′-GCGAGCTCCGCGGCCGCG-3′) and a *p53* 3′-UTR-specific sense primer (5′-CTGGCACCTACAATGAAATCTCAC-3′). Specificity of the PCR reaction was confirmed by digestion of the PCR products with a restriction enzyme (ApaI). The PCR products were resolved on a 10--20% gradient polyacrylamide gel, stained with ethidium bromide, and visualized with an ImageQuant LAS 4000 mini imager (GE Healthcare).

### Western blot.

Cells were lysed in RIP assay buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM EDTA, 1% NP-40, 1% sodium deoxycholate, and 0.05% SDS) containing protease inhibitor cocktail and phosphatase inhibitor cocktail. Equal amounts of each sample were separated by SDS-PAGE and transferred to PVDF membranes (EMD Millipore). Immunoblotting was performed using the following antibodies: anti-CNOT1, CNOT6, CNOT6L, CNOT8, CNOT9, and CNOT10 antibodies described previously ([@bib46]; [@bib7]; [@bib24]); and commercially obtained anti-CNOT2 (Cell Signaling Technology), CNOT3 (clone 4B8; Abnova), CNOT7 (clone 2F6; Abnova), and GAPDH (clone 6C5; EMD Millipore) antibodies.

### 3D DNA-FISH.

3D DNA-FISH was performed essentially as described previously ([@bib58]). In brief, 4 × 10^4^ sorted pro--B cells were attached to poly-[l]{.smallcaps}-lysine--coated coverslips. Cells were fixed in paraformaldehyde, permeabilized, and hybridized with fluorescently labeled BAC probes (provided by C. Bossen and C. Murre, University of California, San Diego, La Jolla, CA). BAC RP24-189H12 (distal V~H~J558) or RP23-404D8 (proximal V~H~7183) was labeled with Cy3-dUTP (GE Healthcare), and BAC RP23-109B20 (C~H~) was labeled with Alexa Fluor 488--dUTP (Invitrogen) using a Nick Translation kit (Roche). The nuclear periphery was stained with anti--Lamin B1 antibody (M-20; Santa Cruz Biotechnology, Inc.) and Alexa Fluor 647--anti--goat antibody (Invitrogen). Image stacks were captured with an inverted microscope IX71 with an oil immersion objective (UPlanSApo 100× NA 1.40; Olympus) and a high-speed spinning disc confocal unit (CSU-X1; Yokogawa Electric Corp.) equipped with a CCD camera (ORCA-AR; Hamamatsu Photonics). Images were collected at 65-nm pixels in X-Y and 200-nm steps in Z with MetaMorph software (Universal Imaging Corp.) as described previously ([@bib23]). Only cells containing signals of both *Igh* loci were evaluated. The intralocus distances between the probes were calculated using ImageJ software (National Institutes of Health). Statistical analysis was performed with the unpaired Student's *t* test using Prism software (GraphPad Software).

### Statistical analysis.

Statistical analyses were performed by a two-tailed unpaired Student's *t* test using Prism software.

### Online supplemental material.

Table S1 shows the list of differentially expressed genes between control and bKO pro--B cells identified by the RNA-seq analysis. Online supplemental material is available at <http://www.jem.org/cgi/content/full/jem.20150384/DC1>.
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